Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.740
+0.120 (3.31%)
At close: Aug 13, 2025, 4:00 PM
3.730
-0.010 (-0.27%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Altimmune Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Altimmune stock ranges from a low of $12 to a high of $24. The average analyst price target of $17.4 forecasts a 365.24% increase in the stock price over the next year.
Price Target: $17.40 (+365.24%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Altimmune stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +220.86% | Aug 13, 2025 |
| UBS | UBS | Strong Buy Maintains $26 → $24 | Strong Buy | Maintains | $26 → $24 | +541.71% | Aug 13, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +381.28% | Aug 13, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $25 → $15 | Buy | Maintains | $25 → $15 | +301.07% | Jul 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +220.86% | Jun 27, 2025 |
Financial Forecast
Revenue This Year
7.29K
from 20.00K
Decreased by -63.54%
Revenue Next Year
25.26M
from 7.29K
Increased by 346,228.95%
EPS This Year
-1.33
from -1.34
EPS Next Year
-1.45
from -1.33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21,000 | 210.0M | 135.1M | ||
| Avg | 7,292 | 25.3M | 23.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.0% | 2,879,689.4% | 434.9% | ||
| Avg | -63.5% | 346,229.0% | -5.3% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.22 | -0.48 | -0.78 | ||
| Avg | -1.33 | -1.45 | -1.28 | ||
| Low | -1.59 | -2.26 | -1.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.